Volume 1: The Foundation of Value. From Clinical Promise to Commercial Reality
Buch in deiner Nähe kaufen
Beschreibung
Das Buch behandelt die Kommerzialisierung von Medizintechnik-Innovationen. Spezifisch geht es um brillante Technologien in Krankenhäusern scheitern und wie Innovatoren diesen Misserfolg vermeiden.
Every year, billions of euros are invested in medical innovation. Brilliant technologies get built. Clinical data is solid. Regulatory approval is secured. Yet hospitals don't buy them. They languish in pilots that never expand. They disappear into a graveyard of technologies that work but couldn't cross the chasm between clinical promise and commercial reality. The reason is almost never the technology itself—it's the strategy.
Most MedTech companies make the same fundamental mistake: they lead with features. They lead with technology. They hope the market recognizes how good they are. This book reveals why that fails—and how to fix it. Value Architecture is a disciplined approach that flips the conventional wisdom on its head. Instead of building brilliant innovation and hoping for adoption, you start with your customer's most expensive problems. You translate clinical evidence into the language of business. You architect adoption rather than hoping for it. This is a practical blueprint, forged in the demanding healthcare markets of Switzerland, Germany, and Austria, where innovation succeeds only when it addresses real economic problems with rigorous evidence and realistic implementation plans.
If your innovation is languishing in a pilot. If procurement keeps saying "maybe." If you're watching inferior competitors outmaneuver you in the market—this book is for you. Learn the frameworks, master the discipline, follow a real innovation's journey from pilot to standard of care. Stop filling the graveyard. Start architecting the future of healthcare.
Autor*in
Kirill Novotarskiy
Kirill Novotarskiy is a healthcare commercialization strategist and Value Architecture consultant based in Switzerland. For fifteen years, he has guided over 120 medical technology companies through the commercialization challenge—helping innovations move from clinical conception to market adoption and, critically, to actual implementation in healthcare systems. His particular expertise lies in the rigorous healthcare markets of Switzerland, Germany, and Austria, where he has developed deep relationships with hospital procurement teams, CFOs, and health technology assessment bodies. Novotarskiy holds degrees from ETH Zurich and the University of St. Gallen, and regularly publishes and lectures on healthcare innovation strategy.
Themen in »Volume 1: The Foundation of Value. From Clinical Promise to Commercial Reality«
Medizintechnik-Kommerzialisierun Healthcare Innovation Strategy Value Architecture Reimbursement-First Strategy Budget Impact Model Health Economics Payer Strategy